Insulin should be discussed early with patients who are beginning to show progression of their diabetes to ease the transition when the time to start insulin therapy arrives.
Insulin should be discussed early with patients who are beginning to show progression of their diabetes to ease the transition when the time to start insulin therapy arrives.
Iatrogenic hypoglycemia, which is most commonly driven by insulin but can be due to other antidiabetic agents, is a common problem for patients with diabetes.
Iatrogenic hypoglycemia, which is most commonly driven by insulin but can be due to other antidiabetic agents, is a common problem for patients with diabetes.